(+)-Grandiforacin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death

49Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Human pancreatic tumors are known to be highly resistant to nutrient starvation, and this prolongs their survival in the hypovascular (austere) tumor microenvironment. Agents that retard this tolerance to nutrient starvation represent a novel antiausterity strategy in anticancer drug discovery. (+)-Grandiforacin (GF), isolated from Uvaria dac, has shown preferential toxicity to PANC-1 human pancreatic cancer cells under nutrient starvation, with a PC50 value of 14.5 μM. However, the underlying mechanism is not clear. In this study, GF was found to preferentially induce PANC-1 cell death in a nutrient-deprived medium via hyperactivation of autophagy, as evidenced by a dramatic upregulation of microtubule-associated protein 1 light chain 3. No change was observed in expression of the caspase-3 and Bcl-2 apoptosis marker proteins. GF was also found to strongly inhibit the activation of Akt, a key regulator of cancer cell survival and proliferation. Because pancreatic tumors are highly resistant to current therapies that induce apoptosis, the alternative cell death mechanism exhibited by GF provides a novel therapeutic insight into antiausterity drug candidates. © 2014 Ueda et al.

Cite

CITATION STYLE

APA

Ueda, J. Y., Athikomkulchai, S., Miyatake, R., Saiki, I., Esumi, H., & Awale, S. (2013). (+)-Grandiforacin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death. Drug Design, Development and Therapy, 8, 39–47. https://doi.org/10.2147/DDDT.S52168

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free